What did @sarahfromtexaspodcast actually say?
Sarah documented her first Wegovy injection on TikTok, walking 138,000-plus viewers through the process in real time. She confirmed her doctor prescribed it, cited climbing cholesterol and loud "food noise" as reasons, and planned to pair it with more protein and movement. Her actual technique claims are the ones worth examining.
Specifically, she demonstrated injecting into her stomach, described pressing down and waiting for two clicks, and told viewers "you really don't feel it." She also said that after the second click, she "won't lose any medicine." These are procedural claims with real accuracy implications for anyone trying to replicate her technique. The good news: she got more right than wrong. The concerning part is what the TikTok format leaves out entirely.
Does the science back this up?
The two-click autoinjector method Sarah describes is accurate for the Wegovy pen, and the abdomen is a clinically approved injection site. The "food noise" reduction she references is one of semaglutide's most documented mechanisms, not just anecdote.
Semaglutide works as a GLP-1 receptor agonist, acting on hypothalamic pathways that regulate appetite and satiety signaling. The STEP 1 trial (Wilding et al., 2021, New England Journal of Medicine) showed a mean 14.9% body weight reduction over 68 weeks in adults with obesity, using the 2.4mg maintenance dose. Food noise, or what researchers call "preoccupation with food thoughts," was measured as a secondary outcome in several STEP trials and showed meaningful reduction. Sarah is describing a real pharmacological effect. The 0.25mg starting dose she is on is a titration dose, not a therapeutic dose, so most of the appetite effects she is hoping for come later in the ramp-up schedule.
What did they get wrong (or right)?
The two-click instruction is correct and worth crediting. The pen is designed so the second click confirms full dose delivery, and pulling away early is a documented reason for partial doses. She got that right.
Where the video misleads by omission: she says "you really don't feel it" as if that is universal. Injection site reactions, including redness, itching, and localized pain, occur in roughly 3-5% of users according to the Wegovy prescribing information. More importantly, she does not mention that 0.25mg is a starter dose, not where the drug's efficacy data comes from. The STEP trials used 2.4mg. Viewers who try one dose and see no weight loss in week one are watching a video that set inaccurate expectations. She also rotates no injection sites on camera, which matters for lipohypertrophy risk over long-term use. To be fair, this is week one and she did not claim to be an expert. But 138,000 people are watching someone learn in real time without the clinical scaffolding that should surround that.
What should you actually know?
If you are starting Wegovy, the injection technique Sarah shows is largely correct, but it is one small piece of a much larger clinical picture that a 60-second TikTok cannot hold.
- The 0.25mg dose is a four-week titration dose. Most clinical outcomes data is from the 2.4mg maintenance dose reached after roughly 16 to 20 weeks of dose escalation.
- Injection site rotation matters. The abdomen, thigh, and upper arm are all approved sites. Injecting the same spot repeatedly raises the risk of lipohypertrophy, which can impair drug absorption (Famulla et al., 2016, Diabetes, Obesity and Metabolism).
- Side effects are real and common. Nausea affects up to 44% of Wegovy users in clinical trials, most often in the first weeks after a dose increase. "You really don't feel it" refers to the needle, not the drug.
- The cholesterol connection Sarah mentions is clinically relevant. A 2023 analysis published in JAMA Cardiology (Bhatt et al.) found semaglutide reduced major cardiovascular events by 20% in high-risk patients, and lipid improvements were part of the mechanism.
- Protein and movement are not optional add-ons. Resistance training alongside GLP-1 therapy is important because semaglutide-driven weight loss includes lean mass loss. Studies suggest 20 to 30% of weight lost on semaglutide can be muscle (Wilding et al., 2021). Sarah mentioned both, which is the right instinct.
Bottom line
Sarah's injection technique is mostly sound, her doctor prescribed it appropriately based on what she shared, and "food noise" is a legitimate documented effect. But a first-injection TikTok from a non-clinician, watched by 138,000 people, cannot substitute for the full picture of what starting Wegovy actually involves, from dose titration timelines to side effect management to injection site rotation. Watch it for relatability. Get your clinical information somewhere else.